As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice
Background: Dexmedetomidine (DEX) is commonly employed as a sedative agent to attenuate sympathetic tone and reduce norepinephrine (NE) levels. In the context of stroke-associated pneumonia (SAP), which is believed to arise from heightened sympathetic nervous system activity and elevated NE release,...
Main Authors: | Miaomiao Zhou, Qiong Luo, Younian Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1203646/full |
Similar Items
-
Association between malnutrition and stroke-associated pneumonia in patients with ischemic stroke
by: Dongze Li, et al.
Published: (2023-08-01) -
Comparison of the Predictive Value of Inflammatory Biomarkers for the Risk of Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
by: Li J, et al.
Published: (2023-09-01) -
Serial ASPECTS to predict stroke-associated pneumonia after thrombolysis in patients with acute ischemic stroke
by: Sarawut Krongsut, et al.
Published: (2024-04-01) -
High Fibrinogen to Albumin Ratio: A Novel Marker for Risk of Stroke-Associated Pneumonia?
by: Gangqiang Lin, et al.
Published: (2022-01-01) -
GNRI, PLR and Stroke-Associated Pneumonia: From Association to Development of a Web-Based Dynamic Nomogram
by: Wang C, et al.
Published: (2023-11-01)